By Counterforce Health Team in Defitelio (defibrotide) —

How to Get Defitelio (Defibrotide) Covered by Cigna in New Jersey: Complete PA Guide and Appeals Process

Answer Box: Getting Defitelio Covered by Cigna in New Jersey

Defitelio (defibrotide) requires prior authorization from Cigna for hepatic VOD/SOS with organ dysfunction post-stem cell transplant. Your transplant physician should call Cigna at 1-800-882-4462 for expedited 72-hour approval. If denied, you have 180 days to file internal appeals, then can request external review through New Jersey's Independent Health Care Appeals Program (IHCAP) via Maximus Federal Services. HMO plans need PCP referrals; PPO/EPO plans don't.

First step today: Have your transplant center contact Cigna's precertification department to initiate the PA process with your HSCT records and VOD/SOS documentation.

Table of Contents

Plan Types & Network Requirements

Understanding your Cigna plan type affects how you access hematology/oncology specialists and where Defitelio can be administered.

Coverage at a Glance

Plan Type PCP Required? Specialist Referral? Network Restrictions Defitelio Coverage
HMO Yes Yes, written referral required In-network only PA required; must use in-network transplant center
PPO No No referrals needed In- and out-of-network (higher costs out-of-network) PA required; any qualified facility
EPO No No referrals needed In-network only PA required; in-network transplant center only
Note: Regardless of plan type, Defitelio administration must occur at a qualified hospital or transplant center with appropriate monitoring capabilities.

For HMO members: Your PCP must provide a written referral to hematology/oncology. Submit referrals via Cigna's provider portal or call 1-866-494-2111.

Formulary Status & Coverage

Defitelio is covered under Cigna's medical benefit (not pharmacy benefit) as an IV-administered specialty drug. It's not subject to traditional formulary tiers since it's administered in hospital settings.

Key Coverage Details

  • Medical Necessity Required: Diagnosis of hepatic VOD/SOS with organ dysfunction following hematopoietic stem cell transplant
  • No Step Therapy: Defitelio is the only FDA-approved treatment for this condition
  • Age Coverage: All ages (pediatric and adult)
  • Site of Care: Must be administered at qualified transplant center

The drug remains covered under Cigna's 2026 policy updates with no changes to coverage criteria.

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Transplant physician calls Cigna at 1-800-882-4462 for expedited review (72 hours for urgent cases)
  2. Submit documentation via electronic portal (CoverMyMeds or Evicore) or fax
  3. Include required evidence: HSCT details, VOD/SOS diagnosis with organ dysfunction proof
  4. Track status through provider portal or patient's myCigna account
  5. Follow up within 48 hours if no initial response
  6. Prepare for peer-to-peer if additional clinical discussion needed
  7. File appeal immediately if denied, within 180-day window

Required Documentation

Your transplant team must provide:

  • HSCT records: Date, type of transplant, conditioning regimen
  • VOD/SOS evidence: Clinical criteria including bilirubin ≥2 mg/dL, weight gain ≥5%, hepatomegaly
  • Organ dysfunction proof: Elevated creatinine, pulmonary complications, or other organ involvement
  • Specialist letter: From transplant physician or hepatologist supporting medical necessity
  • Prior supportive care: Documentation of attempted conservative management
Clinician Corner: Medical necessity letters should reference FDA labeling for hepatic VOD with renal or pulmonary dysfunction, include specific lab values demonstrating organ dysfunction, and cite transplant center protocols. Include FACT or JACIE accreditation status of your facility.

Common Denial Reasons & Solutions

Denial Reason Solution & Documentation Needed
Insufficient VOD/SOS evidence Submit weight gain records, liver function tests, imaging studies showing hepatomegaly
No documented organ dysfunction Provide creatinine levels, oxygen requirements, bilirubin >2 mg/dL documentation
Lack of prior supportive care Include records of attempted fluid management, diuretics, and their failure
Off-label use concerns Reference FDA approval for all ages and cite prescribing information
Site of care issues Confirm facility accreditation (FACT/JACIE) and transplant center status

Appeals Process in New Jersey

New Jersey offers robust appeal rights through the Independent Health Care Appeals Program (IHCAP), now managed by Maximus Federal Services.

Internal Appeals (Required First)

First-Level Appeal

  • Deadline: 180 days from denial
  • Decision timeline: 30 days (15 days for urgent)
  • Submit to: Cigna appeals department via member portal or mail

Second-Level Appeal

  • Deadline: 60 days from first-level denial
  • Decision timeline: 30 days (15 days for urgent)
  • Requirement: Different reviewer than first level

External Review (IHCAP)

After completing internal appeals, New Jersey residents can request external review:

  • Contact: Maximus Federal Services (contracted by NJ DOBI)
  • Deadline: 4 months (180 days) from final internal denial
  • Cost: Free to patients (insurers pay all costs)
  • Timeline: 5 business days for acceptance review, then 45 days for decision (expedited available)
  • Success rate: Approximately 40-60% of specialty drug appeals with strong evidence are overturned

To file external appeal: Contact New Jersey DOBI at 1-888-393-1062 or the Consumer Hotline at 1-800-446-7467 for IHCAP guidance.

From our advocates: We've seen Defitelio appeals succeed when transplant centers provide detailed day-by-day clinical progression showing rapid deterioration and organ dysfunction. The key is demonstrating that conservative management failed and that delay would be life-threatening. This approach helped overturn several initial denials when combined with peer-reviewed literature on VOD outcomes.

When to Request Expedited Review

Request expedited appeals if:

  • Patient shows rapid clinical deterioration
  • Multi-organ failure is developing
  • Transplant team indicates urgent need within 72 hours
  • Standard timeline would jeopardize patient safety

Cost Considerations

Since Defitelio is covered under the medical benefit, costs depend on your plan's hospital/outpatient coverage:

  • HMO/EPO: Typically lower copays for in-network care
  • PPO: Higher coinsurance but more flexibility
  • Deductible: May apply depending on plan design
  • Out-of-pocket maximum: Annual limit protects against excessive costs

Financial Assistance Options

  • Jazz Pharmaceuticals: Offers patient assistance programs (verify eligibility at manufacturer website)
  • Hospital charity care: Most transplant centers have financial assistance programs
  • State programs: New Jersey residents may qualify for additional support through state health programs

FAQ

How long does Cigna PA take in New Jersey? Standard review is 15 business days, but expedited review for urgent cases is 72 hours. Transplant emergencies often qualify for expedited processing.

What if I'm denied for "not medically necessary"? This is the most common denial reason. Your transplant team should provide detailed clinical documentation showing organ dysfunction and failed conservative management. Consider requesting a peer-to-peer review.

Can I get Defitelio if I'm not at a transplant center? No, Cigna requires administration at qualified facilities with appropriate monitoring capabilities. The drug must be given by experienced transplant teams.

Does step therapy apply to Defitelio? No documented step therapy requirements exist since Defitelio is the only FDA-approved treatment for hepatic VOD with organ dysfunction.

What if my transplant was done out of state? Coverage follows your New Jersey Cigna plan rules regardless of where treatment occurred. Ensure your out-of-state facility meets Cigna's network and qualification requirements.

How do I check my appeal status? Log into myCigna portal under "Prescriptions" or "Claims" section. Your transplant center can also check via the provider portal or by calling Cigna directly.

What documents should I keep? Save all denial letters, EOBs, clinical notes, lab results, and correspondence. These are essential for appeals and external review processes.

Can my doctor file the external appeal for me? Yes, New Jersey allows providers to file external appeals on behalf of patients with proper consent. This often results in more complete clinical documentation.

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeals processes for specialty medications like Defitelio.

For complex cases or if you need assistance with your Defitelio appeal, Counterforce Health can help identify the specific denial basis and draft point-by-point rebuttals aligned to Cigna's own coverage policies, pulling the right clinical evidence and meeting all procedural requirements for New Jersey appeals.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal processes may vary by specific plan. Always consult your insurance documents, healthcare providers, and the official New Jersey Department of Banking and Insurance for the most current information regarding your specific situation.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.